Pet company Central Garden & Pet (NASDAQ:CENT) fell short of the market’s revenue expectations in Q1 CY2025, with sales falling 7.4% year on year to $833.5 million. Its non-GAAP profit of $1.04 per share was 11.6% above analysts’ consensus estimates. Is now the time to buy Central Garden & Pet? Find out in our full research report. Central Garden & Pet (CENT) Q1 CY2025 Highlights: Revenue: $833.5 million vs analyst estimates of $878.8 million (7.4% year-on-year decline, 5.1% miss) Adjusted EPS: $1.04 vs analyst estimates of $0.93 (11.6% beat) Adjusted EBITDA: $120.8 million vs analyst estimates of $114.5 million (14.5% margin, 5.5% beat) Management reiterated its full-year Adjusted EPS guidance of $2.20 at the midpoint Operating Margin: 11.2%, in line with the same quarter last year Free Cash Flow was -$57.52 million compared to -$33.87 million in the same quarter last year Market Capitalization: $2.04 billion Company Overview Enhancing the lives of both pets and homeowners, Central Garden & Pet (NASDAQ:CENT) is a leading producer and distributor of essential products for pet care, lawn and garden maintenance, and pest control. Sales Growth Reviewing a company’s long-term sales performance reveals insights into its quality. Even a bad business can shine for one or two quarters, but a top-tier one grows for years. With $3.16 billion in revenue over the past 12 months, Central Garden & Pet carries some recognizable products but is a mid-sized consumer staples company. Its size could bring disadvantages compared to larger competitors benefiting from better brand awareness and economies of scale. As you can see below, Central Garden & Pet’s demand was weak over the last three years. Its sales fell by 2.4% annually, a poor baseline for our analysis.Central Garden & Pet Quarterly Revenue This quarter, Central Garden & Pet missed Wall Street’s estimates and reported a rather uninspiring 7.4% year-on-year revenue decline, generating $833.5 million of revenue. Looking ahead, sell-side analysts expect revenue to grow 3.3% over the next 12 months. Although this projection indicates its newer products will fuel better top-line performance, it is still below the sector average. Software is eating the world and there is virtually no industry left that has been untouched by it. That drives increasing demand for tools helping software developers do their jobs, whether it be monitoring critical cloud infrastructure, integrating audio and video functionality, or ensuring smooth content streaming. Click here to access a free report on our 3 favorite stocks to play this generational megatrend. Story Continues Cash Is King If you’ve followed StockStory for a while, you know we emphasize free cash flow. Why, you ask? We believe that in the end, cash is king, and you can’t use accounting profits to pay the bills. Central Garden & Pet has shown robust cash profitability, giving it an edge over its competitors and the ability to reinvest or return capital to investors. The company’s free cash flow margin averaged 10.4% over the last two years, quite impressive for a consumer staples business. The divergence from its underwhelming operating margin stems from the add-back of non-cash charges like depreciation and stock-based compensation. GAAP operating profit expenses these line items, but free cash flow does not. Taking a step back, we can see that Central Garden & Pet’s margin was unchanged over the last year, showing it recently had a stable free cash flow profile.Central Garden & Pet Trailing 12-Month Free Cash Flow Margin Central Garden & Pet burned through $57.52 million of cash in Q1, equivalent to a negative 6.9% margin. The company’s cash burn increased from $33.87 million of lost cash in the same quarter last year. These numbers deviate from its longer-term margin, indicating it is a seasonal business that must build up inventory during certain quarters. Key Takeaways from Central Garden & Pet’s Q1 Results We enjoyed seeing Central Garden & Pet beat analysts’ EPS and EBITDA expectations this quarter. On the other hand, its revenue missed significantly and its full-year EPS guidance fell short of Wall Street’s estimates. Overall, this was a weaker quarter. The stock remained flat at $34.45 immediately after reporting. Central Garden & Pet’s earnings report left more to be desired. Let’s look forward to see if this quarter has created an opportunity to buy the stock. When making that decision, it’s important to consider its valuation, business qualities, as well as what has happened in the latest quarter. We cover that in our actionable full research report which you can read here, it’s free. View Comments
Central Garden & Pet (NASDAQ:CENT) Reports Sales Below Analyst Estimates In Q1 Earnings
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...